🔬 The Coolest Diffusion Research Isn't in LLMs — Evan Feinberg & Sergey Edunov, Genesis Molecular AI
This episode has a fun personal twist: There’s a counterfactual world where I was employee #1 at Genesis Molecular AI, the company behind today’s episode. A certain introduction happened a few weeks too late and I had already happily signed at Atomwise, another ML-for-drug-discovery startup. Same problem, different…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Latent Space: The AI Engineer Podcast
See all episodes →
64%🔬Scaling Past Informal AI - Carina Hong, Axiom Math
34%🔬Bio-security is an AI Arms Race - Eric Nguyen (CEO, Radical Numerics)
Runway’s WorldPrompt and the Engineering of Real-Time Worlds
Similar episodes from other shows
More like Latent Space: The AI Engineer Podcast →
45%EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
Deep learning technology for drug discovery
Chai-2: The AI Model Accelerating Drug Discovery with Chai Discovery Co-Founders Jack Dent and Joshua Meier
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.